Cramer Won't Buy UnitedHealth Under Probe, But Says Some Think 'The Worst Is Over'

1. Investors scrutinize earnings amid market volatility for growth potential. 2. Jim Cramer dislikes AGNC due to weak growth and earnings performance. 3. Cramer expresses caution about UNH, referencing ongoing investigations. 4. UNH reaffirms its adjusted EPS target of at least $16.00 for 2025. 5. UNH shares rose 8.6% amid positive earnings reassessment.